In addition, SHBG levels were significantly lower in patients with NAFLD than that without (25.78 ± 11.01 nmol/L vs. 45.71 ± 18.1 nmol/L, P< 0.001). The gene discussed is SHBG; the disease is metabolic dysfunction-associated steatotic liver disease.